The 2023 ETF Series Trust II - GMO U.S. Quality ETF
The 2023 ETF Series Trust II - GMO U.S. Quality ETF (QLTY) Stock Overview
Explore The 2023 ETF Series Trust II - GMO U.S. Quality ETF’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.9B
P/E Ratio
N/A
EPS (TTM)
$1.31
ROE
0.00%
QLTY Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of The 2023 ETF Series Trust II - GMO U.S. Quality ETF (QLTY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $25.81.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 1.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
The fund is an actively managed exchange-traded fund that seeks to achieve its investment objective by investing primarily in equities of U.S. companies that the fund’s adviser, Grantham, Mayo, Van Otterloo & Co. LLC (“GMO” or the “Adviser”), believes to be of high quality. Equity securities primarily include common and preferred stocks and, to a lesser extent, other stock-related securities, such as convertible securities, depositary receipts, equity real estate investment trusts, income trusts, and securities of other investment companies that investment primarily in equity securities.
2023